课题基金 / 基金详情

OCULAR HYPERTENSION TREATMENT STUDY (OHTS)

OCULAR HYPERTENSION TREATMENT STUDY (OHTS)
眼压过高治疗研究 (OHTS)
批准号:
7176058
负责人:
Shan Lin
金额:
$10.98万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2008-12-31

项目摘要

项目成果

Shan Lin的其他基金

相似基金

相关文献

中文摘要
翻译
描述(研究者摘要) “这是一个申请成为参与临床中心, 高眼压治疗研究(OHTS)。 完整的细节 OHTS原理、设计和方法包含在OHTS手册中, 程序. 本建议书提供了完整的文件, 加州大学旧金山分校眼科学系 弗朗西斯科筛查大量高眼压患者, 在24个月内招募至少50名合格患者。 提供了关于拟议调查员能力的文件 及其工作人员进行研究的雅阁 OHTS程序手册,其承诺的性质和范围 到UCSF,和从业人员名单(除了机构工作人员) 将转诊或随访接受入组和随机化筛选的患者 OHTS临床试验中的治疗。"
英文摘要
DESCRIPTION (Investigator's Abstract) "This is an application to become a participating Clinical Center in the Ocular Hypertension Treatment Study (OHTS). The complete details of the OHTS rationale, design, and methods are contained in the OHTS Manual of Procedures. This proposal provides complete documentation of the ability of the Department of Ophthalmology at the University of California at San Francisco to screen large numbers of ocular hypertensive patients and to enroll at least 50 eligible patients over a 24 month period. Documentation is provided of the capabilities of the proposed investigators and their staff for the performance of the study in accord with the details of the OHTS Manual of Procedures, the nature and extent of their commitment to UCSF, and a list of practitioners (in addition to institutional staff) who will refer or follow patients screened for enrollment and randomization to treatment in the OHTS clinical trial."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia
  • 批准号:
    10284146
  • 项目类别:
  • 资助金额:
    $13.61万
  • 财政年份:
    2021
  • 负责人:
    Shan Lin
  • 依托单位:
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia
  • 批准号:
    10473763
  • 项目类别:
  • 资助金额:
    $13.61万
  • 财政年份:
    2021
  • 负责人:
    Shan Lin
  • 依托单位:
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data